Healthcare

According to a new market report published by Lucintel, the future of the global interventional cardiology and peripheral vascular device market looks good with opportunities in hospitals and ambulatory surgical centers. The global interventional cardiology and peripheral vascular device market is expected to reach an estimated $31.6 billion by 2027 and is forecast to grow at a CAGR of 5.6% from 2022 to 2027. The major drivers for the growing elderly population and rise in prevalence of chronic diseases  and advancements in medical technology and research.

In this market, interventional cardiology and peripheral vascular are the main segments by type. On the basis of comprehensive research, Lucintel forecasts that interventional cardiology is expected to witness significant growth over the forecast period because of new technology innovations and aging population.

Within global interventional cardiology and peripheral vascular device market, the largest segment by end user is projected to be hospitals due to the growing public-private partnerships to improve access to healthcare services along with rapid developments in healthcare infrastructure and improving access to healthcare services. These are the major driving factors for growth in this segment over the forecast period.

North America is expected to remain the largest region because it is a large pharmaceutical manufacturing base and the region is witnessing increasing technological advancements in interventional cardiology and peripheral vascular devices.   

APAC is expected to witness the highest growth rate over the forecast period due to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, rising per capita income, growing middle-class population, and growing prevalence of tobacco smoking in this region.

Emerging trends, which have a direct impact on the dynamics of the industry, include rising adoption of TAVR procedure, increasing use of bioresorbable stents and rising adoption of drug eluting balloons. Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronics Public Limited Company, C. R. Bard, Inc., Cook Medical Inc., Terumo Corporation, and Cardinal Health Inc are among the major suppliers of the interventional cardiology and peripheral vascular device  market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global interventional cardiology and peripheral vascular device  market by type, device, end user, and region, and has compiled a comprehensive research report entitled “Growth Opportunities in the Global Interventional Cardiology and Peripheral Vascular Device  Market 2022-2027: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy by providing a comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global interventional cardiology and peripheral vascular device market by type, device, end user, and region, as follows:


































This 201-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx or write us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

This report addresses the following key questions:

Q.1 What are some of the most promising, growth opportunities for global interventional cardiology and peripheral vascular device  market by type (interventional cardiology and peripheral vascular device), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC filter, embolic protection device, guidewires, arteriotomy closure device, intravascular ultrasound system, and synthetic surgical graft), end user (hospitals and ambulatory surgical centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2 Which segments will grow at a faster pace and why?

Q.3 Which region will grow at a faster pace and why?

Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges, and business risks in this market?

Q.5 What are the business risks and competitive threats in this market?

Q.6 What are the emerging trends in this market and the reasons behind them?

Q.7 What are some of the changing demands of customers in the market?

Q.8 What are the new developments in the market and which companies are leading these developments?

Q.9 Who are the major players in this market? What strategic initiatives are being taken by key players for business growth?

Q.10 What are some of the competing products in this market and how big of a threat do they pose for loss of market share by product substitution?

Q.11 What M & A activity has occurred in the last 5 years?